Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
Christopher S StrouseSarah L MottBrian J SmithMargarida Magalhaes-SilvermanUmar FarooqFenghuang ZhanYogesh JethavaGuido TricotPublished in: Bone marrow transplantation (2023)
Keyphrases